Assignee
INTERLUDE BIOPHARMA CO
US·2 granted patents·3 pending applications·0 citations·filing 2020–2025
Top patents by PatentIndex Score
5 records- 0166US2024325463A1Compositions and methods for treating or preventing intestinal paracellular permeabilityINTERLUDE BIOPHARMA CO·Filed 2024·Application pending·0 cites
- 0258US2026034191A1Larazotide formulationsINTERLUDE BIOPHARMA CO·Filed 2025·Application pending·0 cites
- 0357US12337024B2Larazotide formulationsINTERLUDE BIOPHARMA CO·Filed 2020·Granted Jun 24, 2025·0 cites·17 claims
- 0448US2025144166A1Compositions and methods for inhibiting rho kinaseINTERLUDE BIOPHARMA CO·Filed 2023·Application pending·0 cites
- 0547US12414979B2Compositions and methods for treating Sjogren's syndromeINTERLUDE BIOPHARMA CO·Filed 2021·Granted Sep 16, 2025·0 cites·10 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →